Virpax Pharmaceuticals (VRPX) Insider Trading & Ownership → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free VRPX Stock Alerts $2.92 -0.25 (-7.89%) (As of 02:34 PM ET) Add Compare Share Share Insider TradesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Virpax Pharmaceuticals (NASDAQ:VRPX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.23%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$228,906.00Number OfInsiders Selling(Last 3 Years)0 Get VRPX Insider Trade Alerts Want to know when executives and insiders are buying or selling Virpax Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VRPX Insider Buying and Selling by Quarter Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide Virpax Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/24/2022Jerrold SendrowDirectorBuy450$12.90$5,805.00 5/18/2022Anthony P MackCEOBuy7,575$13.40$101,505.00 5/18/2022Eric FloydDirectorBuy447$13.60$6,079.20 11/22/2021Jerrold SendrowDirectorBuy390$39.20$15,288.00 11/18/2021Anthony P MackCEOBuy2,512$39.90$100,228.80 (Data available from 1/1/2013 forward) VRPX Insider Trading Activity - Frequently Asked Questions Who is on Virpax Pharmaceuticals's Insider Roster? The list of insiders at Virpax Pharmaceuticals includes Anthony P Mack, Eric Floyd, and Jerrold Sendrow. Learn more on insiders at VRPX. What percentage of Virpax Pharmaceuticals stock is owned by insiders? 6.23% of Virpax Pharmaceuticals stock is owned by insiders. Learn more on VRPX's insider holdings. Which Virpax Pharmaceuticals insiders have been buying company stock? The following insiders have purchased VRPX shares in the last 24 months: Anthony P Mack ($101,505.00), Eric Floyd ($6,079.20), and Jerrold Sendrow ($5,805.00). How much insider buying is happening at Virpax Pharmaceuticals? Insiders have purchased a total of 8,472 VRPX shares in the last 24 months for a total of $113,389.20 bought. More Insider Trading Tools from MarketBeat Related Companies: MBIO Insider Selling GOVX Insider Selling PHAS Insider Selling REVB Insider Selling HILS Insider Selling ENSC Insider Selling PHIO Insider Selling SNGX Insider Selling BCEL Insider Selling ARTL Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:VRPX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Goldtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe AI stock to buy right nowStockEarningsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virpax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
